IRWD FY 2022 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$411M-0.8% YoY

Gross Profit

$409M99.7% margin

Operating Income

$250M61.0% margin

Net Income

$175M42.6% margin

EPS (Diluted)

$0.96

Cash Flow

Operating Cash Flow

$274M

Free Cash Flow

$274M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$448M

Stockholders' Equity

$652M

Cash & Equivalents

$656M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$411M	$414M	-0.8%
Gross Profit	$409M	$343M	+19.2%
Operating Income	$250M	$232M	+7.8%
Net Income	$175M	$528M	-66.9%